Skip to content

Clinical trials

Phase 3 Neutropenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neutropenia Phase: Phase 3 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20082
20091
20112
20121
20162
20171
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group3
EVIVE Biotechnology2
Spectrum Pharmaceuticals, Inc2
Amgen1
Carelon Research1
Jonsson Comprehensive Cancer Center1
Memorial Sloan Kettering Cancer Center1
National Cancer Institute (NCI)1
National Institute of Allergy and Infectious Diseases (NIAID)1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neutropenia19
Breast Neoplasms7
Fever6
Infections4
Neoplasms4
HIV Infections3
Hot Flashes3
Leukemia, Biphenotypic, Acute3
Leukemia, Myeloid, Acute3
Mycoses3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.